More than 30 years of senior management experience in Logistics, Threat Management and Security.
Mitch is also Executive Director of Strategic Initiatives for the Agility Logistics group.
In a prior role, Mitch has served as Vice President, Middle East & Africa, International Critical Infrastructure Solutions in SOC, a leading company providing mission support to military clients.
Prior to that, Mitch was Vice President in the Threat Management Group, an Agility subsidiary.
Mitch brings experience in preparedness, logistics and strategic management of resources, hence complementing other GRA team members’ strengths in pharmaceuticals with his operational expertise in distribution and logistics.

Executive and entrepreneur with more than 30 years experience in Management, M&A, Strategy Consulting and Pharma.
Alex was named the youngest partner at EY at the age of 28. At EY, Alex served as head of the European Strategy Group and co-head of the Technology Innovation Center in Fairfax, VA.
Following EY, Alex became a Partner at Value Partners, a management consulting firm spun out of McKinsey. At Value Partners, Alex led the ‘Value Team’ as co-CEO for the group and CEO for South America, where he managed over 5,000 employees and more than $500M in revenue.
Alex founded MPayMe in Hong Kong, the first technology startup to accept payments on mobile via QR Codes, and which was sold to Powa UK in 2014 in a multi-million-dollar transaction.
At EY and Value Partners, Alex advised numerous leading multinational pharma companies as a Strategy and Business consultant, gaining a profound understanding of the sector.
Alex holds undergraduate degrees in math and statistics, a Ph.D. in Physician Executive MBA sponsored by EY, and a commercial pilot license with more than 8,000 hours of flight time.

Mary joined Global Response Aid bringing 20 years of experience in the healthcare industry. Prior to joining the team, Mary co-founded a digital health business providing on-demand access to physicians and specialists. From 2008 to 2013, Mary co-founded a specialist pharmaceutical development company focused on implantable therapies for opioid addiction disease. Her interest in niche pharmaceutical manufacturing developed from a 2.5-year contract project managing the establishment of Ireland’s first compounding facility, supplying a broad range of extemporaneously compounded medicinal products. From 2000 to 2006 Mary was employed by an fund investing with retail pharmacy in Ireland. Mary holds an MA in HRM, BA HRM and a BSC in Marketing.

John has over 25 years' experience in private practice, during this time he spent 16 years as a Partner of international law firm Baker Botts. His experiences include project development and finance, project and asset finance, corporate M&A, joint ventures and international trade

In response to the COVID-19 pandemic, Dr. Kaszynski co-founded the “Global Unified plAtform for the Rapid Development and Investigation of therApeutics for Novel Pandemics (GUARDIAN)” program in collaboration with the Imperial College (London) to optimize clinical studies during outbreaks and pandemics.
Dr. Kaszynski is one of the few physician-scientists with operational and academic experience involving the use of favipiravir and has been instrumental in establishing international COVID-19 clinical trials spanning five continents.
As a Senior Medical Advisor to the Democratic Republic of Congo (DRC), Dr. Kaszynski worked together with the Coordinator General of the Ebola response to identify and implement novel strategies to help combat/contain the Ebola outbreak. It was during the 2019 Ebola outbreak in the North Kivu and Ituri provinces in the DRC where Dr. Kaszynski, together with the DRC Ministry of Foreign Affairs and the Coordinator General for the Ebola outbreak agreed upon proposals for operational deployment of favipiravir in a post-exposure prophylactic capacity.
Dr. Kaszynski holds a Doctor of Medicine from Kobe University (Japan) and was a Fellow at Harvard Medical School, Massachusetts General Hospital in the Department of Anesthesia, Critical Care and Pain Medicine (Boston, MA).